Clinical trial

Good-first: B/F/TAF As First-line ART

NCT06619288

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2024-07-01

PhaseN/A

Study timeline

Study start (actual)2024-07-01Date precision: day

Registry last updated2024-10-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionunresolved

Interventions

B/F/TAFDRUG

TDF+3TC+EFVDRUG

DTG/3TCDRUG

Sponsors & collaborators

Affiliated Hospital of Nantong Universitylead sponsor

Nantong Third Peoples Hospitalcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06619288 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.